The number of people with susceptibility test result for rifampicin in Chile
Chile: The number of people with susceptibility test result for rifampicin was 96.15 in 2021. ▲ Rising
Latest (2021)
96.15
Change on year
up 5.3%
World rank
46th
of 146 countries
All-time high
96.15
in 2021
All-time low
82.57
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Chile, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Chile stood at 96.15. That is the highest value across all 5 years on record.
That represents a change of up 5.3% on the previous year and up 16.5% over five years.
That places Chile 46th out of 146 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in Chile, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 82.57 | — |
| 2018 | 84.39 | +2.2% |
| 2019 | 90.37 | +7.1% |
| 2020 | 91.29 | +1.0% |
| 2021 | 96.15 | +5.3% |
Chile compared with similar countries
- Chile's 96.15 is above the median for high income countries, which is 92.6, 1.0× the median. (56 countries reporting)
- Chile's 96.15 is above the median for Latin America & Caribbean, which is 59.38, 1.6× the median. (21 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 85.78 | 82.57 | 90.37 | 3 |
| 2020s | 93.72 | 91.29 | 96.15 | 2 |
Countries ranked near Chile
More health data for Chile
- Un projection of annual infant deaths, annual growth rate -1.71 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.4062 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,755 deaths per 1,000 people (2090)
- Number of infants who die before age 1 115 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -3.22 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0224 units per person (2025)
- Population ages 00-04, male, annual growth rate -3.16 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Chile?
- The number of people with susceptibility test result for rifampicin in Chile was 96.15 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Chile?
- The highest recorded value was 96.15 in 2021.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Chile?
- The lowest recorded value was 82.57 in 2017.
- How does Chile rank for the number of people with susceptibility test result for rifampicin?
- Chile ranks 46th out of 146 countries with data for 2021.
- Where does this Chile data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).